UB Paderborn / Katalog / Suche / in CDI

Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease

Hepatology research, 2008-11, Vol.38 (11), p.1122-1129

2008

Volltextzugriff (PDF)

Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease

International journal of molecular medicine, 2007-09, Vol.20 (3), p.351-358

2007

Volltextzugriff (PDF)

Potential role of branched-chain amino acids in glucose metabolism through the accelerated induction of the glucose-sensing apparatus in the liver

Journal of cellular biochemistry, 2011-01, Vol.112 (1), p.30-38

2011

Volltextzugriff (PDF)

effects of unsaturated fatty acids on lipid metabolism in HepG2 cells

In vitro cellular & developmental biology. Animal, 2009, Vol.45 (1-2), p.6-9

2009

Volltextzugriff (PDF)

Methylprednisolone injection via the portal vein suppresses inflammation in acute liver failure induced in rats by lipopolysaccharide and d-galactosamine

Liver international, 2007-12, Vol.27 (10), p.1342-1348

2007

Volltextzugriff (PDF)

SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease

International journal of molecular medicine, 2008-04, Vol.21 (4), p.507-511

2008

Volltextzugriff (PDF)

Direct-acting antiviral agents do not increase the incidence of hepatocellular carcinoma development: a prospective, multicenter study

Hepatology international, 2019-05, Vol.13 (3), p.293-301

2019

Volltextzugriff (PDF)

Reduced hepatic expression of adipose tissue triglyceride lipase and CGI-58 may contribute to the development of non-alcoholic fatty liver disease in patients with insulin resistance

Scandinavian journal of gastroenterology, 2008-01, Vol.43 (8), p.1018-1019

2008

Volltextzugriff (PDF)

Impact of cholesterol metabolism and the LXRα-SREBP-1c pathway on nonalcoholic fatty liver disease

International journal of molecular medicine, 2009-05, Vol.23 (5), p.603-608

2009

Volltextzugriff (PDF)

Endoscope Positioning System (UPD-3) Can Be Applicable for Objective, Easy Recording and Judging of Locations of Colonic Polyps in Routine Colonoscopies: 1532

The American journal of gastroenterology, 2015-10, Vol.110, p.S663

2015

Volltextzugriff (PDF)

Therapeutic effect of ARBs on insulin resistance and liver injury in patients with NAFLD and chronic hepatitis C: A pilot study

International journal of molecular medicine, 2008-10, Vol.22 (4), p.521-527

2008

Volltextzugriff (PDF)

The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease

International journal of molecular medicine, 2008-11, Vol.22 (5), p.663-667

2008

Volltextzugriff (PDF)

Changes in the expression of cholesterol metabolism-associated genes in HCV-infected liver: A novel target for therapy?

International journal of molecular medicine, 2009-12, Vol.24 (6), p.825-828

2009

Volltextzugriff (PDF)

NIM811, a nonimmunosuppressive cyclosporine analogue, suppresses collagen production and enhances collagenase activity in hepatic stellate cells

Liver international, 2007-11, Vol.27 (9), p.1273-1281

2007

Volltextzugriff (PDF)

The state of cholesterol metabolism in the liver of patients with primary biliary cirrhosis: the role of MDR3 expression

Hepatology international, 2009-09, Vol.3 (3), p.490-496

2009

Volltextzugriff (PDF)

277 Srebp1c, Regulated By the Insulin, Ampk, and LXRα Signaling Pathways, Plays a Role in NAFLD: Importance of Cholesterol∼Lxra∼Srebp1c Axis and the Cholesterol Metabolism

Gastroenterology (New York, N.Y. 1943), 2008, Vol.134 (4), p.A-761-A-762

2008

Volltextzugriff (PDF)

4 A Dramatic Alteration in the Cholesterol Metabolism in An HCV Infected-Liver: the Implications for HCV Infection and Treatment

Gastroenterology (New York, N.Y. 1943), 2008, Vol.134 (4), p.A-750-A-750

2008

Volltextzugriff (PDF)

A case of hepatocellular carcinoma with respiratory failure caused by widespread tumor microemboli

Fukuoka igaku zasshi = Hukuoka acta medica, 2011-10, Vol.102 (10), p.298-302

2011

Volltextzugriff (PDF)

Impact of cholesterol metabolism and the LXRalpha-SREBP-1c pathway on nonalcoholic fatty liver disease

International journal of molecular medicine, 2009-05, Vol.23 (5), p.603-608

2009

Volltextzugriff (PDF)

Investigation of hyperuricemia during pegylated-interferon-α2b plus ribavirin combination therapy in patients with chronic hepatitis C

Journal of digestive diseases, 2008-02, Vol.9 (1), p.27-31

2008

Volltextzugriff (PDF)

A case of breakthrough hepatitis caused by HBV-DNA mutations after 4 years combination therapy of Lamivudine and Adefovir dipivoxil

Kanzo, 2009, Vol.50(9), pp.514-519

2009

Volltextzugriff (PDF)

Investigation of hyperuricemia during pegylated-interferon-alpha2b plus ribavirin combination therapy in patients with chronic hepatitis C

Journal of digestive diseases, 2008-02, Vol.9 (1), p.27-31

2008

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease

Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease

Potential role of branched-chain amino acids in glucose metabolism through the accelerated induction of the glucose-sensing apparatus in the liver

Factors Contributing to the Prognosis after Second-line Therapy with Ramucirumab in Advanced Hepatocellular Carcinoma

Predictors of hepatocellular carcinoma recurrence associated with the use of direct‐acting antiviral agent therapy for hepatitis C virus after curative treatment: A prospective multicenter cohort study

effects of unsaturated fatty acids on lipid metabolism in HepG2 cells

Methylprednisolone injection via the portal vein suppresses inflammation in acute liver failure induced in rats by lipopolysaccharide and d-galactosamine

SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease

Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma progressing after molecular targeted therapy: A multicenter prospective observational study

Direct-acting antiviral agents do not increase the incidence of hepatocellular carcinoma development: a prospective, multicenter study

Reduced hepatic expression of adipose tissue triglyceride lipase and CGI-58 may contribute to the development of non-alcoholic fatty liver disease in patients with insulin resistance

Impact of cholesterol metabolism and the LXRα-SREBP-1c pathway on nonalcoholic fatty liver disease

Endoscope Positioning System (UPD-3) Can Be Applicable for Objective, Easy Recording and Judging of Locations of Colonic Polyps in Routine Colonoscopies: 1532

Therapeutic effect of ARBs on insulin resistance and liver injury in patients with NAFLD and chronic hepatitis C: A pilot study

The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease

Changes in the expression of cholesterol metabolism-associated genes in HCV-infected liver: A novel target for therapy?

NIM811, a nonimmunosuppressive cyclosporine analogue, suppresses collagen production and enhances collagenase activity in hepatic stellate cells

The state of cholesterol metabolism in the liver of patients with primary biliary cirrhosis: the role of MDR3 expression

277 Srebp1c, Regulated By the Insulin, Ampk, and LXRα Signaling Pathways, Plays a Role in NAFLD: Importance of Cholesterol∼Lxra∼Srebp1c Axis and the Cholesterol Metabolism

4 A Dramatic Alteration in the Cholesterol Metabolism in An HCV Infected-Liver: the Implications for HCV Infection and Treatment

A case of hepatocellular carcinoma with respiratory failure caused by widespread tumor microemboli

Impact of cholesterol metabolism and the LXRalpha-SREBP-1c pathway on nonalcoholic fatty liver disease

Investigation of hyperuricemia during pegylated-interferon-α2b plus ribavirin combination therapy in patients with chronic hepatitis C

A case of breakthrough hepatitis caused by HBV-DNA mutations after 4 years combination therapy of Lamivudine and Adefovir dipivoxil

Investigation of hyperuricemia during pegylated-interferon-alpha2b plus ribavirin combination therapy in patients with chronic hepatitis C

Suchergebnisse filtern